Search research articles
Contact Us
Filters
Showing results (31-40 of 53) with videos related to
Page
of 6
Sort By:
Multiple Sclerosis and Related Disorders
|
February 15, 2022
Temporal trends of multiple sclerosis disease activity: Electronic health records indicators
Liang Liang, Nicole Kim, Jue Hou, et al.
Journal of Neurosurgery
|
September 26, 2002
Endoscopic third ventriculostomy in patients with cerebrospinal fluid infection and/or hemorrhage
Vitaly Siomin, Giuseppe Cinalli, Andre Grotenhuis, et al.
Leukemia & Lymphoma
|
March 5, 2024
Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapy
Rafael Madero-Marroquin, Emily Dworkin, Howard Weiner, et al.
Archives of Neurology
|
July 15, 2009
Smoking and disease progression in multiple sclerosis
Brian C Healy, Eman N Ali, Charles R G Guttmann, et al.
Leukemia & Lymphoma
|
June 12, 2010
Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplant
Lucy A Godley, Uchenna O Njiaju, Margaret Green, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 1, 2026
Tobacco smoking disrupts bile acid and tryptophan metabolism in multiple sclerosis
Farren Bs Briggs, Jevin Litwiler, Federico Montini, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 1, 2025
Dimethyl fumarate protects from experimental autoimmune encephalomyelitis by modulating colonic immune cells
Amanda Dias Da Rocha Lima, Marília G De Oliveira, Breno Ferrari, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
October 31, 2015
Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis
Riley Bove, Charles C White, Gavin Giovannoni, et al.
Journal of Hematology & Oncology
|
January 7, 2018
A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia
Amy Y Wang, Howard Weiner, Margaret Green, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 13, 2026
ODC1 restricts meningeal B cell age-associated-like phenotype and function in multiple sclerosis: A human and experimental study
Jonathan Zurawski, Alara Tuncer, Martin R Profant, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 53) with videos related to
Sort By:
Page
of 6
Multiple Sclerosis and Related Disorders
|
February 15, 2022
Temporal trends of multiple sclerosis disease activity: Electronic health records indicators
Liang Liang, Nicole Kim, Jue Hou, et al.
Journal of Neurosurgery
|
September 26, 2002
Endoscopic third ventriculostomy in patients with cerebrospinal fluid infection and/or hemorrhage
Vitaly Siomin, Giuseppe Cinalli, Andre Grotenhuis, et al.
Leukemia & Lymphoma
|
March 5, 2024
Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapy
Rafael Madero-Marroquin, Emily Dworkin, Howard Weiner, et al.
Archives of Neurology
|
July 15, 2009
Smoking and disease progression in multiple sclerosis
Brian C Healy, Eman N Ali, Charles R G Guttmann, et al.
Leukemia & Lymphoma
|
June 12, 2010
Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplant
Lucy A Godley, Uchenna O Njiaju, Margaret Green, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 1, 2026
Tobacco smoking disrupts bile acid and tryptophan metabolism in multiple sclerosis
Farren Bs Briggs, Jevin Litwiler, Federico Montini, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 1, 2025
Dimethyl fumarate protects from experimental autoimmune encephalomyelitis by modulating colonic immune cells
Amanda Dias Da Rocha Lima, Marília G De Oliveira, Breno Ferrari, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
October 31, 2015
Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis
Riley Bove, Charles C White, Gavin Giovannoni, et al.
Journal of Hematology & Oncology
|
January 7, 2018
A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia
Amy Y Wang, Howard Weiner, Margaret Green, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 13, 2026
ODC1 restricts meningeal B cell age-associated-like phenotype and function in multiple sclerosis: A human and experimental study
Jonathan Zurawski, Alara Tuncer, Martin R Profant, et al.
Page
of 6